Meyer Handelman Company’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.12M | Sell |
47,507
-20,287
| -30% | -$1.94M | 0.13% | 103 |
|
|
2025
Q4 | $6.51M | Sell |
67,794
-8,172
| -11% | -$794K | 0.2% | 89 |
|
|
2025
Q3 | $7.24M | Sell |
75,966
-3,826
| -5% | -$352K | 0.23% | 88 |
|
|
2025
Q2 | $6.96M | Sell |
79,792
-15,610
| -16% | -$1.32M | 0.23% | 89 |
|
|
2025
Q1 | $8.57M | Sell |
95,402
-11,366
| -11% | -$1.02M | 0.3% | 78 |
|
|
2024
Q4 | $8.53M | Sell |
106,768
-39,673
| -27% | -$3.43M | 0.3% | 78 |
|
|
2024
Q3 | $13.2M | Sell |
146,441
-18,344
| -11% | -$1.54M | 0.45% | 61 |
|
|
2024
Q2 | $13M | Sell |
164,785
-23,322
| -12% | -$1.91M | 0.46% | 62 |
|
|
2024
Q1 | $16.4M | Sell |
188,107
-21,441
| -10% | -$1.83M | 0.57% | 53 |
|
|
2023
Q4 | $17.3M | Hold |
209,548
| – | – | 0.67% | 49 |
|
|
2023
Q3 | $16.4M | Sell |
209,548
-100
| -0% | -$8.37K | 0.66% | 50 |
|
|
2023
Q2 | $18.5M | Sell |
209,648
-8,044
| -4% | -$693K | 0.75% | 44 |
|
|
2023
Q1 | $17.6M | Sell |
217,692
-4,126
| -2% | -$336K | 0.73% | 44 |
|
|
2022
Q4 | $17.2M | Sell |
221,818
-9,224
| -4% | -$748K | 0.72% | 47 |
|
|
2022
Q3 | $18.7M | Sell |
231,042
-1,017
| -0.4% | -$91.4K | 0.86% | 38 |
|
|
2022
Q2 | $20.8M | Sell |
232,059
-13,400
| -5% | -$1.36M | 0.89% | 38 |
|
|
2022
Q1 | $27.2M | Buy |
245,459
+3,076
| +1% | +$325K | 1.04% | 30 |
|
|
2021
Q4 | $25.1M | Buy |
242,383
+868
| +0.4% | +$101K | 0.93% | 37 |
|
|
2021
Q3 | $30.3M | Sell |
241,515
-800
| -0.3% | -$104K | 1.24% | 24 |
|
|
2021
Q2 | $30.1M | Sell |
242,315
-6,853
| -3% | -$860K | 1.19% | 25 |
|
|
2021
Q1 | $29.4M | Sell |
249,168
-3,064
| -1% | -$359K | 1.22% | 25 |
|
|
2020
Q4 | $29.5M | Buy |
252,232
+2,917
| +1% | +$321K | 1.34% | 22 |
|
|
2020
Q3 | $25.9M | Sell |
249,315
-1,717
| -0.7% | -$172K | 1.32% | 23 |
|
|
2020
Q2 | $23M | Hold |
251,032
| – | – | 1.23% | 28 |
|
|
2020
Q1 | $22.6M | Hold |
251,032
| – | – | 1.39% | 21 |
|
|
2019
Q4 | $28.5M | Sell |
251,032
-1,913
| -0.8% | -$210K | 1.37% | 22 |
|
|
2019
Q3 | $27.5M | Hold |
252,945
| – | – | 1.39% | 22 |
|
|
2019
Q2 | $24.6M | Sell |
252,945
-430
| -0.2% | -$39.3K | 1.26% | 23 |
|
|
2019
Q1 | $23.3M | Hold |
253,375
| – | – | 1.21% | 25 |
|
|
2018
Q4 | $23M | Sell |
253,375
-4,910
| -2% | -$459K | 1.3% | 23 |
|
|
2018
Q3 | $25.4M | Sell |
258,285
-4,983
| -2% | -$461K | 1.24% | 26 |
|
|
2018
Q2 | $22.5M | Hold |
263,268
| – | – | 1.16% | 29 |
|
|
2018
Q1 | $21.1M | Sell |
263,268
-994
| -0.4% | -$82K | 1.08% | 34 |
|
|
2017
Q4 | $21.3M | Sell |
264,262
-63,324
| -19% | -$5.07M | 1.02% | 34 |
|
|
2017
Q3 | $25.5M | Buy |
327,586
+13,221
| +4% | +$1.1M | 1.16% | 29 |
|
|
2017
Q2 | $27.9M | Sell |
314,365
-2,021
| -0.6% | -$170K | 1.18% | 29 |
|
|
2017
Q1 | $25.5M | Buy |
316,386
+5,990
| +2% | +$468K | 1.09% | 36 |
|
|
2016
Q4 | $22.1M | Buy |
310,396
+4,000
| +1% | +$314K | 0.98% | 40 |
|
|
2016
Q3 | $26.5M | Hold |
306,396
| – | – | 1.19% | 27 |
|
|
2016
Q2 | $26.6M | Sell |
306,396
-4,755
| -2% | -$385K | 1.19% | 26 |
|
|
2016
Q1 | $23.3M | Buy |
311,151
+14,566
| +5% | +$1.1M | 1.08% | 31 |
|
|
2015
Q4 | $22.8M | Sell |
296,585
-564
| -0.2% | -$42.5K | 1.08% | 33 |
|
|
2015
Q3 | $19.9M | Buy |
297,149
+5,699
| +2% | +$420K | 1.01% | 36 |
|
|
2015
Q2 | $21.6M | Buy |
291,450
+10,622
| +4% | +$812K | 0.99% | 35 |
|
|
2015
Q1 | $21.9M | Buy |
+280,828
| New | +$21.3M | 0.99% | 35 |
|
Other funds holding MDT
VCM
VPM
Meyer Handelman Company's MDT Position: Q1 2026 in Review
Meyer Handelman Company reduced its Medtronic (MDT) stake by 30% in Q1 2026, selling an estimated $1.94M and leaving 47,507 shares worth $4.12M. The position accounts for 0.13% of the portfolio, ranked #103.
Meyer Handelman Company first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $30.3M in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Meyer Handelman Company held 47,507 shares of Medtronic worth $4.12M as of Q1 2026.
- Meyer Handelman Company sold 20,287 Medtronic shares in Q1 2026, an estimated $1.94M.
- Medtronic made up 0.13% of Meyer Handelman Company's portfolio in Q1 2026, its #103 holding.
- Meyer Handelman Company first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
- Meyer Handelman Company's Medtronic position peaked at $30.3M in Q3 2021.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.